Okamura, R., Kato, S., Lee, S., Jimenez, R. E., Sicklick, J. K., & Kurzrock, R. (2020). ARID1A alterations function as a biomarker for longer progression-free survival after anti-PD-1/PD-L1 immunotherapy. J Immunother Cancer.

Okamura, Ryosuke, Shumei Kato, Suzanna Lee, Rebecca E. Jimenez, Jason K. Sicklick, and Razelle Kurzrock. "ARID1A Alterations Function As a Biomarker for Longer Progression-free Survival After Anti-PD-1/PD-L1 Immunotherapy." J Immunother Cancer 2020.

Okamura, Ryosuke, et al. "ARID1A Alterations Function As a Biomarker for Longer Progression-free Survival After Anti-PD-1/PD-L1 Immunotherapy." J Immunother Cancer 2020.